SCHEMBL31668182

SCHEMBL31668182

O=C(CCCC(=O)OCc1cc(Br)cc(Br)c1O)OCc1cc(Br)cc(Br)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
GFER P55789 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
MAPT P10636 3/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
PLEC Q15149 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9319210 1.00 TTR (0.41) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL9319479 0.97 TTR (0.41) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL6248837 0.95 TTR (0.40) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL6053862 0.93 CYP3A4 (0.43) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL20659945 0.91 TTR (0.41) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL27515109 0.90 TTR (0.40) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL29586703 0.88 TTR (0.43) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL7750809 0.80 TTR (0.39) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL87887 0.79 HCAR2 (0.43) TTRCYP3A4TSHRTDP1AKR1C4
SCHEMBL1122760 0.79 HCAR2 (0.43) TTRCYP3A4TSHRTDP1AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570600-B2 Multifunctional linker compounds 20Bloc, Inc. (US) 2026-03-10 US disclosed
US-20250353897-A1 HEMOGLOBIN-BASED OXYGEN CARRIER COMPOSITIONS 20Bloc, Inc. 2025-11-20 US disclosed
US-20250243148-A1 MULTIFUNCTIONAL LINKER COMPOUNDS 20Bloc, Inc. 2025-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250243148-A1 MULTIFUNCTIONAL LINKER COMPOUNDS F13A1, MRPL21, SRRM2 TTR 2965/4885CYP3A4 4664/4885TSHR 2716/4885
US-20250353897-A1 HEMOGLOBIN-BASED OXYGEN CARRIER COMPOSITIONS HBB, HBG1, HBG2 TTR 161/4885CYP3A4 725/4885TSHR 2045/4885
US-12570600-B2 Multifunctional linker compounds CHN2, RCC2, COG1 TTR 1998/4885CYP3A4 4602/4885TSHR 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.